IP Library Granted Patent US 11,918,700
Granted Patent B2
US 11,918,700 · App. 17/268,441 · Granted Mar 5, 2024

Skin compatible silicone composition

Inventors: Lloyd Pearce (Skipton, GB); Stewart Lee (Skipton, GB)
Assignee: TRIO HEALTHCARE LTD
A61L24/046A61F5/448A61L24/0031A61L24/06A61L24/08C08G77/08C08G77/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,918,700
App. No.
17/268,441
Granted
Mar 5, 2024
Kind
B2
Abstract

A skin compatible component attachable to mammalian skin. The component is formed as a silicone matrix comprising a polyorganosiloxane derived silicone polymer and a moisture control particulate and permeability modifying polymer distributed within the polymer network. The skin compatible component may be utilised as an ostomy wafer or flange to secure an ostomy appliance to the skin and in particular peri-stomal skin.

Claims (37)

1. A skin compatible component attachable to mammalian skin comprising:

a silicone polymer network derived from the addition curing of a first part including a vinyl functionalised siloxane polymer and a second part including a silicon hydride containing crosslinker, in the presence of a metal catalyst;

a superabsorbent particulate distributed within the polymer network configured to absorb moisture from the skin;

characterised by:

a permeability modifying polymer being a polyester distributed within the polymer network and having hydrophobic and hydrophilic domains.

2. The component as claimed in claim 1 wherein the superabsorbent particulate has an average particle size less than 150 μm.

3. The component as claimed in claim 1 wherein the superabsorbent particulate comprises an average particle size in the range 10 to 40 μm, 15 to 35 μm or 20 to 30 μm.

4. The component as claimed in claim 1 wherein the superabsorbent particulate is distributed within the polymer network at a concentration in the range 5 to 45 wt %, 10 to 40 wt %, 15 to 35 wt % or 20 to 30 wt %.

5. The component as claimed in claim 1 wherein the superabsorbent particulate comprises any one or a combination of the set of:

a naturally occurring hydrocolloid;

a semi-synthetic hydrocolloid; and

a synthetic hydrocolloid.

6. The component as claimed in claim 1 wherein the superabsorbent particulate comprises any one or a combination of:

a polysaccharide;

a cellulose;

hydroxyethylcellulose;

carboxymethylcellulose; and

hydroxypropylcellulose.

7. The component as claimed in claim 1 wherein the superabsorbent particulate comprises any one or a combination of:

carboxymethyl β-glucan;

cross-linked sodium carboxymethyl cellulose;

sodium carboxymethyl cellulose; and

methylcellulose.

8. The component as claimed in claim 1 wherein the superabsorbent particulate comprises sodium polyacrylate.

9. The component as claimed in claim 1 wherein an organosilicone resin is included in the first or second part prior to addition curing.

10. The component as claimed in claim 9 wherein the organosilicone resin is an MQ resin.

11. The component as claimed in claim 1 wherein a cohesive strengthening agent is included in the first part or the second part prior to addition curing.

12. The component as claimed in claim 11 wherein the cohesive strengthening agent comprises any one or a combination of the set of: fumed silica, fumed alumina, colloidal silica, nanoclays, silicates, silane treated organic polymers, polymeric metal oxides, and non-polymeric metal oxides.

13. The component as claimed in claim 1 wherein the permeability modifying polymer is not chemically bonded to the silicone polymer network.

14. The component as claimed in claim 1 wherein the polyester comprises polycaprolactone (PCL).

15. The component as claimed in claim 1 comprising the permeability modifying polymer at 0.1 to 5.0 wt %; 0.1 to 4.0 wt %; 0.1 to 3.0 wt %; 0.1 to 2.0 wt %; 0.2 to 1.8 wt %; 0.2 to 1.6 wt %; 0.2 to 1.2 wt %; 0.2 to 1.0 wt %; 0.2 to 0.8 wt %; 0.2 to 0.4 wt %; or 0.6 to 1.0 wt %.

16. A skin compatible component attachable to mammalian skin manufactured by a method comprising:

mixing a first part including a vinyl functionalized siloxane polymer with a second part including a silicon hydride containing crosslinker to form a mix;

incorporating within the mix a superabsorbent particulate;

incorporating within the mix a permeability modifying polymer being a polyester having hydrophobic and hydrophilic domains; and

curing the mix via a metal catalyst;

wherein the superabsorbent particulate and the polyester are distributed within the resulting addition cured silicone polymer network.

Assignments (3)
TERMINATION AND RELEASE OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Dec 9, 2024
From: SWK FUNDING LLC
To: TRIO HEALTHCARE LIMITED
Reel/Frame 069547/0792 →
SECURITY INTEREST Recorded Jul 12, 2021
From: TRIO HEALTHCARE LIMITED
To: SWK FUNDING LLC
Reel/Frame 056829/0619 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2021
From: PEARCE, LLOYD; LEE, STEWART
To: TRIO HEALTHCARE LTD
Reel/Frame 055275/0611 →
Priority Claims (1)
GB 1904403 · Mar 29, 2019 · national
Continuity (1)
Related Publication 20210346569A1 · Nov 11, 2021